KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

BioNTech SE (BNTX) Income from Continuing Operations: 2017-2024

Historic Income from Continuing Operations for BioNTech SE (BNTX) over the last 8 years, with Dec 2024 value amounting to -$710.9 million.

  • BioNTech SE's Income from Continuing Operations fell 30.31% to $91.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$516.0 million, marking a year-over-year decrease of 188.70%. This contributed to the annual value of -$710.9 million for FY2024, which is 171.03% down from last year.
  • Latest data reveals that BioNTech SE reported Income from Continuing Operations of -$710.9 million as of FY2024, which was down 171.03% from $1.0 billion recorded in FY2023.
  • In the past 5 years, BioNTech SE's Income from Continuing Operations registered a high of $11.8 billion during FY2021, and its lowest value of -$710.9 million during FY2024.
  • For the 3-year period, BioNTech SE's Income from Continuing Operations averaged around $3.3 billion, with its median value being $1.0 billion (2023).
  • Per our database at Business Quant, BioNTech SE's Income from Continuing Operations soared by 64,869.65% in 2021 and then slumped by 171.03% in 2024.
  • Yearly analysis of 5 years shows BioNTech SE's Income from Continuing Operations stood at $18.1 million in 2020, then spiked by 64,869.65% to $11.8 billion in 2021, then declined by 18.25% to $9.6 billion in 2022, then tumbled by 89.60% to $1.0 billion in 2023, then plummeted by 171.03% to -$710.9 million in 2024.